These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2889870)

  • 1. Criteria for severe aplastic anaemia.
    Rozman C; Marín P; Nomdedeu B; Montserrat E
    Lancet; 1987 Oct; 2(8565):955-7. PubMed ID: 2889870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation.
    Lohrmann HP; Kern P; Niethammer D; Heimpel H
    Lancet; 1976 Sep; 2(7987):647-50. PubMed ID: 60514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
    Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
    Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplastic anaemia in childhood: prognosis and approach to therapy.
    Windass B; Vowels MR; Hughes DO; White L
    Med J Aust; 1987 Jan; 146(1):15-9. PubMed ID: 3540547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Leibundgut U; Ruggero D; Osterwalder B; Burri HP; Cornu P; Jeannet M
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):860-3. PubMed ID: 6783204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions.
    Speck B; Gluckman E; Haak HL; van Rood JJ
    Lancet; 1977 Dec; 2(8049):1145-8. PubMed ID: 73059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The action of antilymphocyte serum in severe aplastic anemia (author's transl)].
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Nouv Presse Med; 1978 Feb; 7(6):439-43. PubMed ID: 634781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thymocyte globulin treatment for aplastic anemia.
    Jansen J; Zwaan FE; Haak HL; te Velde J; Guiot HF; Sabbe LJ; Eernisse JG; Tricot GJ; van Rood JJ
    Scand J Haematol; 1982 Apr; 28(4):341-51. PubMed ID: 7051265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in acquired aplastic anemia. An approach in the selection of patients for allogeneic bone marrow transplantation.
    Hellriegel KP; Züger M; Gross R
    Blut; 1977 Jan; 34(1):11-8. PubMed ID: 318877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 11. Regeneration of peripheral blood cells following allogeneic bone marrow transplantation for severe aplastic anaemia.
    Hows JM; Kaffaf S; Palmer S; Harris R; Fairhead S; Gordon-Smith EC
    Br J Haematol; 1982 Dec; 52(4):551-8. PubMed ID: 6753913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Prog Clin Biol Res; 1984; 148():249-58. PubMed ID: 6379663
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
    N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
    Bacigalupo A
    Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT).
    Gluckman E; Devergie A; Poros A; Degoulet P
    Br J Haematol; 1982 Aug; 51(4):541-50. PubMed ID: 7049219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis-oriented therapy of aplastic anemia].
    Helbig W
    Z Gesamte Inn Med; 1983 Feb; 38(3):71-5. PubMed ID: 6342281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
    Găman A; Găman G; Bold A
    Rom J Morphol Embryol; 2009; 50(4):669-74. PubMed ID: 19942964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy associated aplastic anaemia: a report of five cases and review of current management.
    Aitchison RG; Marsh JC; Hows JM; Russell NH; Gordon-Smith EC
    Br J Haematol; 1989 Dec; 73(4):541-5. PubMed ID: 2611139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia: the role of immunosuppression.
    Billett HH
    Hosp Pract (Off Ed); 1992 Aug; 27(8):35, 39-40, 43 passim. PubMed ID: 1644876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.